The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Disease Management Software Market Research Report 2024

Global Disease Management Software Market Research Report 2024

Publishing Date : Feb, 2024

License Type :
 

Report Code : 1900066

No of Pages : 86

Synopsis
Disease management software is a type of software that provides tools for managing the symptoms, treatment, and prevention of chronic diseases. Chronic diseases are long-term conditions that require ongoing medical care and affect the quality of life of patients. Examples of chronic diseases include diabetes, asthma, cancer, heart disease, and arthritis. Disease management software helps patients, caregivers, and health care providers to monitor, track, and improve the health outcomes of patients with chronic diseases. Disease management software typically offers features such as data collection and analysis, care coordination and communication, patient education and engagement, medication management and adherence, and clinical decision support.
The global Disease Management Software market was valued at US$ 69 million in 2023 and is anticipated to reach US$ 140.2 million by 2030, witnessing a CAGR of 10.5% during the forecast period 2024-2030.
The industry trend of disease management software is influenced by the increasing prevalence and burden of chronic diseases, the growing adoption of digital health technologies, and the changing needs and expectations of patients and providers. Some of the key trends are:
Cloud computing: Cloud computing is the delivery of computing services over the internet, such as servers, storage, databases, networking, software, analytics, etc. Cloud computing offers many benefits for disease management software users, such as scalability, flexibility, cost-efficiency, security, reliability, and accessibility. Cloud computing also enables disease management software users to access their data and applications from any device and location.
Artificial intelligence: Artificial intelligence is the simulation of human intelligence processes by machines, such as learning, reasoning, problem-solving, etc. Artificial intelligence can enhance the capabilities and functionalities of disease management software in various ways, such as providing personalized recommendations for treatment or prevention based on user data or behavior, analyzing user data to generate insights and feedback for improving their health6, creating interactive and immersive experiences for users through virtual reality or augmented reality, etc.
Omnichannel experience: Omnichannel experience is the integration of multiple channels of communication and interaction between a business and its customers. Omnichannel experience aims to provide a seamless, consistent, and personalized customer experience across different touchpoints. For disease management software users, omnichannel experience means being able to access their health information and services through various platforms such as web-based portals, mobile apps, wearable devices, smart speakers, etc.
This report aims to provide a comprehensive presentation of the global market for Disease Management Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Disease Management Software.
Report Scope
The Disease Management Software market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Disease Management Software market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Disease Management Software companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Elsevier
emr4MD
AHT Care Management
Guiding Care
HUMHEALTH
LexisNexis
ACUITY Advanced Care
AveCare
AviTracks-DM
Ayogo
ChronicWatch
Segment by Type
Cloud Based
Web Based
Segment by Application
Hospitals
Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Disease Management Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Disease Management Software Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Cloud Based
1.2.3 Web Based
1.3 Market by Application
1.3.1 Global Disease Management Software Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Disease Management Software Market Perspective (2019-2030)
2.2 Disease Management Software Growth Trends by Region
2.2.1 Global Disease Management Software Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Disease Management Software Historic Market Size by Region (2019-2024)
2.2.3 Disease Management Software Forecasted Market Size by Region (2025-2030)
2.3 Disease Management Software Market Dynamics
2.3.1 Disease Management Software Industry Trends
2.3.2 Disease Management Software Market Drivers
2.3.3 Disease Management Software Market Challenges
2.3.4 Disease Management Software Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Disease Management Software Players by Revenue
3.1.1 Global Top Disease Management Software Players by Revenue (2019-2024)
3.1.2 Global Disease Management Software Revenue Market Share by Players (2019-2024)
3.2 Global Disease Management Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Disease Management Software Revenue
3.4 Global Disease Management Software Market Concentration Ratio
3.4.1 Global Disease Management Software Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Disease Management Software Revenue in 2023
3.5 Disease Management Software Key Players Head office and Area Served
3.6 Key Players Disease Management Software Product Solution and Service
3.7 Date of Enter into Disease Management Software Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Disease Management Software Breakdown Data by Type
4.1 Global Disease Management Software Historic Market Size by Type (2019-2024)
4.2 Global Disease Management Software Forecasted Market Size by Type (2025-2030)
5 Disease Management Software Breakdown Data by Application
5.1 Global Disease Management Software Historic Market Size by Application (2019-2024)
5.2 Global Disease Management Software Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Disease Management Software Market Size (2019-2030)
6.2 North America Disease Management Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Disease Management Software Market Size by Country (2019-2024)
6.4 North America Disease Management Software Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Disease Management Software Market Size (2019-2030)
7.2 Europe Disease Management Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Disease Management Software Market Size by Country (2019-2024)
7.4 Europe Disease Management Software Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Disease Management Software Market Size (2019-2030)
8.2 Asia-Pacific Disease Management Software Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Disease Management Software Market Size by Region (2019-2024)
8.4 Asia-Pacific Disease Management Software Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Disease Management Software Market Size (2019-2030)
9.2 Latin America Disease Management Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Disease Management Software Market Size by Country (2019-2024)
9.4 Latin America Disease Management Software Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Disease Management Software Market Size (2019-2030)
10.2 Middle East & Africa Disease Management Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Disease Management Software Market Size by Country (2019-2024)
10.4 Middle East & Africa Disease Management Software Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Elsevier
11.1.1 Elsevier Company Detail
11.1.2 Elsevier Business Overview
11.1.3 Elsevier Disease Management Software Introduction
11.1.4 Elsevier Revenue in Disease Management Software Business (2019-2024)
11.1.5 Elsevier Recent Development
11.2 emr4MD
11.2.1 emr4MD Company Detail
11.2.2 emr4MD Business Overview
11.2.3 emr4MD Disease Management Software Introduction
11.2.4 emr4MD Revenue in Disease Management Software Business (2019-2024)
11.2.5 emr4MD Recent Development
11.3 AHT Care Management
11.3.1 AHT Care Management Company Detail
11.3.2 AHT Care Management Business Overview
11.3.3 AHT Care Management Disease Management Software Introduction
11.3.4 AHT Care Management Revenue in Disease Management Software Business (2019-2024)
11.3.5 AHT Care Management Recent Development
11.4 Guiding Care
11.4.1 Guiding Care Company Detail
11.4.2 Guiding Care Business Overview
11.4.3 Guiding Care Disease Management Software Introduction
11.4.4 Guiding Care Revenue in Disease Management Software Business (2019-2024)
11.4.5 Guiding Care Recent Development
11.5 HUMHEALTH
11.5.1 HUMHEALTH Company Detail
11.5.2 HUMHEALTH Business Overview
11.5.3 HUMHEALTH Disease Management Software Introduction
11.5.4 HUMHEALTH Revenue in Disease Management Software Business (2019-2024)
11.5.5 HUMHEALTH Recent Development
11.6 LexisNexis
11.6.1 LexisNexis Company Detail
11.6.2 LexisNexis Business Overview
11.6.3 LexisNexis Disease Management Software Introduction
11.6.4 LexisNexis Revenue in Disease Management Software Business (2019-2024)
11.6.5 LexisNexis Recent Development
11.7 ACUITY Advanced Care
11.7.1 ACUITY Advanced Care Company Detail
11.7.2 ACUITY Advanced Care Business Overview
11.7.3 ACUITY Advanced Care Disease Management Software Introduction
11.7.4 ACUITY Advanced Care Revenue in Disease Management Software Business (2019-2024)
11.7.5 ACUITY Advanced Care Recent Development
11.8 AveCare
11.8.1 AveCare Company Detail
11.8.2 AveCare Business Overview
11.8.3 AveCare Disease Management Software Introduction
11.8.4 AveCare Revenue in Disease Management Software Business (2019-2024)
11.8.5 AveCare Recent Development
11.9 AviTracks-DM
11.9.1 AviTracks-DM Company Detail
11.9.2 AviTracks-DM Business Overview
11.9.3 AviTracks-DM Disease Management Software Introduction
11.9.4 AviTracks-DM Revenue in Disease Management Software Business (2019-2024)
11.9.5 AviTracks-DM Recent Development
11.10 Ayogo
11.10.1 Ayogo Company Detail
11.10.2 Ayogo Business Overview
11.10.3 Ayogo Disease Management Software Introduction
11.10.4 Ayogo Revenue in Disease Management Software Business (2019-2024)
11.10.5 Ayogo Recent Development
11.11 ChronicWatch
11.11.1 ChronicWatch Company Detail
11.11.2 ChronicWatch Business Overview
11.11.3 ChronicWatch Disease Management Software Introduction
11.11.4 ChronicWatch Revenue in Disease Management Software Business (2019-2024)
11.11.5 ChronicWatch Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’